Abstract:Background: Pathological cardiac hypertrophy induced by stresses such as aging and neurohumoral activation is an independent risk factor for heart failure and is considered a target for the treatment of heart failure. However, the mechanisms underlying pathological cardiac hypertrophy remain largely unknown. We aimed to investigate the roles of SIRT2 in aging-related and angiotensin II (Ang II)–induced pathological cardiac hypertrophy. Methods: Male C57BL/6J wild-type and Sirt2 knockout mice were subjected to the investigation of aging-related cardiac hypertrophy. Cardiac hypertrophy was also induced by Ang II (1.3 mg/kg/d for 4 weeks) in male C57BL/6J Sirt2 knockout mice, cardiac-specific SIRT2 transgenic ( SIRT2 -Tg) mice, and their respective littermates (8 to ≈12 weeks old). Metformin (200 mg/kg/d) was used to treat wild-type and Sirt2 knockout mice infused with Ang II. Cardiac hypertrophy, fibrosis, and cardiac function were examined in these mice. Results: SIRT2 protein expression levels were downregulated in hypertrophic hearts from mice. Sirt2 knockout markedly exaggerated cardiac hypertrophy and fibrosis and decreased cardiac ejection fraction and fractional shortening in aged (24-month-old) mice and Ang II–infused mice. Conversely, cardiac-specific SIRT2 overexpression protected the hearts against Ang II–induced cardiac hypertrophy and fibrosis and rescued cardiac function. Mechanistically, SIRT2 maintained the activity of AMP-activated protein kinase (AMPK) in aged and Ang II–induced hypertrophic hearts in vivo as well as in cardiomyocytes in vitro. We identified the liver kinase B1 (LKB1), the major upstream kinase of AMPK, as the direct target of SIRT2. SIRT2 bound to LKB1 and deacetylated it at lysine 48, which promoted the phosphorylation of LKB1 and the subsequent activation of LKB1-AMPK signaling. Remarkably, the loss of SIRT2 blunted the response of AMPK to metformin treatment in mice infused with Ang II and repressed the metformin-mediated reduction of cardiac hypertrophy and protection of cardiac function. Conclusions: SIRT2 promotes AMPK activation by deacetylating the kinase LKB1. Loss of SIRT2 reduces AMPK activation, promotes aging-related and Ang II–induced cardiac hypertrophy, and blunts metformin-mediated cardioprotective effects. These findings indicate that SIRT2 will be a potential target for therapeutic interventions in aging- and stress-induced cardiac hypertrophy.

SIRT2 Deficiency Prevents Age-Related Bone Loss in Rats by Inhibiting Osteoclastogenesis.

Sirtuin 3 (SIRT3) maintains bone homeostasis by regulating AMPK-PGC-1β axis in mice

SIRT2 Regulates Extracellular Vesicle-Mediated Liver-Bone Communication

Role of Sirtuins in Bone Biology: Potential Implications for Novel Therapeutic Strategies for Osteoporosis.

Mitochondrial Sirt3 contributes to the bone loss caused by aging or estrogen deficiency

Sirt3 mediates the benefits of exercise on bone in aged mice

SIRT3/SOD2 Maintains Osteoblast Differentiation and Bone Formation by Regulating Mitochondrial Stress

SIRT1 maintains bone homeostasis by regulating osteoblast glycolysis through GOT1

Sirt1 is Involved in Decreased Bone Formation in Aged Apolipoprotein E-deficient Mice

Mitochondrial protein deacetylation by SIRT3 in osteoclasts promotes bone resorption with aging in female mice

Sirtuin 3 Deficiency Exacerbates Age-Related Periodontal Disease.

Role of SIRT3 in Bone Homeostasis and Its Application in Preventing and Treating Bone Diseases

SIRT2 Acts As a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.

SIRT1/FOXO3a Axis Plays an Important Role in the Prevention of Mandibular Bone Loss Induced by 1,25(OH)2D Deficiency

Cellular senescence as a key factor in osteoporosis: the role of SIRT1

SIRT2 inhibition protects against cardiac hypertrophy and heart failure

Sirtuin 2 deficiency aggravates ageing-induced vascular remodelling in humans and mice

Sirt1: An Increasingly Interesting Molecule with a Potential Role in Bone Metabolism and Osteoporosis

Hypoxia-inducible factor-2α mediates senescence-associated intrinsic mechanisms of age-related bone loss

NDR2 is Critical for the Osteoclastogenesis by Regulating ULK1-mediated Mitophagy.

Abstract 186: Impaired Nucleocytoplasmic Shuttling and Activity of SIRT1 in Response to Ischemic Stress in the Senescent Heart